IHT Wealth Management LLC grew its position in Colgate-Palmolive (NYSE:CL – Free Report) by 37.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 21,377 shares of the company’s stock after buying an additional 5,869 shares during the period. IHT Wealth Management LLC’s holdings in Colgate-Palmolive were worth $2,196,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth $25,000. Continuum Advisory LLC boosted its position in shares of Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive during the third quarter worth about $53,000. Finally, Prospera Private Wealth LLC bought a new position in Colgate-Palmolive during the third quarter worth about $64,000. 80.41% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CL has been the topic of several recent analyst reports. JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday, November 25th. Finally, Wells Fargo & Company cut their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.
Colgate-Palmolive Trading Up 0.2 %
Shares of CL stock opened at $94.81 on Thursday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The stock has a market cap of $77.46 billion, a P/E ratio of 27.17, a price-to-earnings-growth ratio of 3.47 and a beta of 0.43. The stock has a 50 day simple moving average of $96.89 and a 200 day simple moving average of $98.63. Colgate-Palmolive has a 1 year low of $75.50 and a 1 year high of $109.30.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.11%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is presently 57.31%.
Insiders Place Their Bets
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.37% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- Dividend Capture Strategy: What You Need to Know
- Tesla Poised to Hit Record Highs This Holiday Season
- How to Use the MarketBeat Dividend Calculator
- The Salesforce Rally is Just Getting Started: Here’s Why
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.